These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

342 related articles for article (PubMed ID: 28083916)

  • 21. BIN1 recovers tauopathy-induced long-term memory deficits in mice and interacts with Tau through Thr
    Sartori M; Mendes T; Desai S; Lasorsa A; Herledan A; Malmanche N; Mäkinen P; Marttinen M; Malki I; Chapuis J; Flaig A; Vreulx AC; Ciancia M; Amouyel P; Leroux F; Déprez B; Cantrelle FX; Maréchal D; Pradier L; Hiltunen M; Landrieu I; Kilinc D; Herault Y; Laporte J; Lambert JC
    Acta Neuropathol; 2019 Oct; 138(4):631-652. PubMed ID: 31065832
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A Dual Pathogenic Mechanism Links Tau Acetylation to Sporadic Tauopathy.
    Trzeciakiewicz H; Tseng JH; Wander CM; Madden V; Tripathy A; Yuan CX; Cohen TJ
    Sci Rep; 2017 Mar; 7():44102. PubMed ID: 28287136
    [TBL] [Abstract][Full Text] [Related]  

  • 23. X-linked ubiquitin-specific peptidase 11 increases tauopathy vulnerability in women.
    Yan Y; Wang X; Chaput D; Shin MK; Koh Y; Gan L; Pieper AA; Woo JA; Kang DE
    Cell; 2022 Oct; 185(21):3913-3930.e19. PubMed ID: 36198316
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Functional networks are impaired by elevated tau-protein but reversible in a regulatable Alzheimer's disease mouse model.
    Green C; Sydow A; Vogel S; Anglada-Huguet M; Wiedermann D; Mandelkow E; Mandelkow EM; Hoehn M
    Mol Neurodegener; 2019 Mar; 14(1):13. PubMed ID: 30917861
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Reduction of advanced tau-mediated memory deficits by the MAP kinase p38γ.
    Ittner A; Asih PR; Tan ARP; Prikas E; Bertz J; Stefanoska K; Lin Y; Volkerling AM; Ke YD; Delerue F; Ittner LM
    Acta Neuropathol; 2020 Sep; 140(3):279-294. PubMed ID: 32725265
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Tau pathology induces loss of GABAergic interneurons leading to altered synaptic plasticity and behavioral impairments.
    Levenga J; Krishnamurthy P; Rajamohamedsait H; Wong H; Franke TF; Cain P; Sigurdsson EM; Hoeffer CA
    Acta Neuropathol Commun; 2013 Jul; 1():34. PubMed ID: 24252661
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Tau Proteins and Tauopathies in Alzheimer's Disease.
    Chong FP; Ng KY; Koh RY; Chye SM
    Cell Mol Neurobiol; 2018 Jul; 38(5):965-980. PubMed ID: 29299792
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Identification of retinoblastoma binding protein 7 (Rbbp7) as a mediator against tau acetylation and subsequent neuronal loss in Alzheimer's disease and related tauopathies.
    Dave N; Vural AS; Piras IS; Winslow W; Surendra L; Winstone JK; Beach TG; Huentelman MJ; Velazquez R
    Acta Neuropathol; 2021 Aug; 142(2):279-294. PubMed ID: 33978814
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Physiological and Pathophysiological Implications of Synaptic Tau.
    Regan P; Whitcomb DJ; Cho K
    Neuroscientist; 2017 Apr; 23(2):137-151. PubMed ID: 26908138
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Synaptic Mitochondria: An Early Target of Amyloid-β and Tau in Alzheimer's Disease.
    Torres AK; Jara C; Park-Kang HS; Polanco CM; Tapia D; Alarcón F; de la Peña A; Llanquinao J; Vargas-Mardones G; Indo JA; Inestrosa NC; Tapia-Rojas C
    J Alzheimers Dis; 2021; 84(4):1391-1414. PubMed ID: 34719499
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Mechanism of Oxidative Stress and Synapse Dysfunction in the Pathogenesis of Alzheimer's Disease: Understanding the Therapeutics Strategies.
    Kamat PK; Kalani A; Rai S; Swarnkar S; Tota S; Nath C; Tyagi N
    Mol Neurobiol; 2016 Jan; 53(1):648-661. PubMed ID: 25511446
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Regulation of Tau Homeostasis and Toxicity by Acetylation.
    Tracy T; Claiborn KC; Gan L
    Adv Exp Med Biol; 2019; 1184():47-55. PubMed ID: 32096027
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Cognitive defects are reversible in inducible mice expressing pro-aggregant full-length human Tau.
    Van der Jeugd A; Hochgräfe K; Ahmed T; Decker JM; Sydow A; Hofmann A; Wu D; Messing L; Balschun D; D'Hooge R; Mandelkow EM
    Acta Neuropathol; 2012 Jun; 123(6):787-805. PubMed ID: 22532069
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Argyrophilic grain disease differs from other tauopathies by lacking tau acetylation.
    Grinberg LT; Wang X; Wang C; Sohn PD; Theofilas P; Sidhu M; Arevalo JB; Heinsen H; Huang EJ; Rosen H; Miller BL; Gan L; Seeley WW
    Acta Neuropathol; 2013 Apr; 125(4):581-93. PubMed ID: 23371364
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Pharmacologic inhibition of 5-lipoxygenase improves memory, rescues synaptic dysfunction, and ameliorates tau pathology in a transgenic model of tauopathy.
    Giannopoulos PF; Chu J; Sperow M; Li JG; Yu WH; Kirby LG; Abood M; Praticò D
    Biol Psychiatry; 2015 Nov; 78(10):693-701. PubMed ID: 25802082
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Acetylation changes tau interactome to degrade tau in Alzheimer's disease animal and organoid models.
    Choi H; Kim HJ; Yang J; Chae S; Lee W; Chung S; Kim J; Choi H; Song H; Lee CK; Jun JH; Lee YJ; Lee K; Kim S; Sim HR; Choi YI; Ryu KH; Park JC; Lee D; Han SH; Hwang D; Kyung J; Mook-Jung I
    Aging Cell; 2020 Jan; 19(1):e13081. PubMed ID: 31763743
    [TBL] [Abstract][Full Text] [Related]  

  • 37. RPS23RG1 reduces Aβ oligomer-induced synaptic and cognitive deficits.
    Yan L; Chen Y; Li W; Huang X; Badie H; Jian F; Huang T; Zhao Y; Cohen SN; Li L; Zhang YW; Luo H; Tu S; Xu H
    Sci Rep; 2016 Jan; 6():18668. PubMed ID: 26733416
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Novel Lipidized Analog of Prolactin-Releasing Peptide Improves Memory Impairment and Attenuates Hyperphosphorylation of Tau Protein in a Mouse Model of Tauopathy.
    Popelová A; Pražienková V; Neprašová B; Kasperová BJ; Hrubá L; Holubová M; Zemenová J; Blum D; Železná B; Galas MC; Kuneš J; Maletínská L
    J Alzheimers Dis; 2018; 62(4):1725-1736. PubMed ID: 29614684
    [TBL] [Abstract][Full Text] [Related]  

  • 39. SIRT1 Deacetylates Tau and Reduces Pathogenic Tau Spread in a Mouse Model of Tauopathy.
    Min SW; Sohn PD; Li Y; Devidze N; Johnson JR; Krogan NJ; Masliah E; Mok SA; Gestwicki JE; Gan L
    J Neurosci; 2018 Apr; 38(15):3680-3688. PubMed ID: 29540553
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Acetylated tau exacerbates learning and memory impairment by disturbing with mitochondrial homeostasis.
    Liu Q; Wang X; Hu Y; Zhao JN; Huang CH; Li T; Zhang BG; He Y; Wu YQ; Zhang ZJ; Wang GP; Liu GP
    Redox Biol; 2023 Jun; 62():102697. PubMed ID: 37037158
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 18.